← Leaderboards
Fred H Hochberg
Massachusetts General Hospital
$3,701,108
Attributed
$5,748,379
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2006–17$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$24,821,768 · 9
By mechanism
P01$20,229,778 · 4
UH3$3,022,165 · 1
UH2$1,072,378 · 1
U01$462,481 · 1
P51$24,966 · 1
R13$10,000 · 1
Top collaborators
- Bob S Carter7 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Robert L Martuza$21,256,149
- Ralph Weissleder$110,468,710
- Xandra Owens Breakefield$30,735,276
- Aparna Raj Parikh$1,079,955
- Andrew T Chan$39,910,857
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaBrain NeoplasmsClinical TrialsResearch PersonnelGene TherapyClinical ResearchTumorSensitivity And SpecificityProgramsQuality Of LifeBiological MarkersTumor TissuePublicationsPre-ClinicalBrainEpidermal Growth Factor Receptor ViiiProtocols DocumentationDiagnosisMutationInstitutionNeoplasm /Cancer TherapyScientific OrganizationExome SequencingAlgorithms
Grant awards (40)
exRNA Biomarkers for Human Glioma$960,890
UH3 · FY2017 · TR
exRNA Biomarkers for Human Glioma$972,585
UH3 · FY2016 · TR
Administration and neuropathology oversight$127,742
P01 · FY2016 · CA · contact PI
exRNA Biomarkers for Human Glioma$984,048
UH3 · FY2015 · TR
Administration and neuropathology oversight$128,208
P01 · FY2015 · CA · contact PI
exRNA Biomarkers for Human Glioma$104,642
UH3 · FY2015 · TR
exRNA Biomarkers for Human Glioma$494,879
UH2 · FY2014 · TR
Administration and neuropathology oversight$121,367
P01 · FY2014 · CA · contact PI
exRNA Biomarkers for Human Glioma$77,500
UH2 · FY2014 · TR
exRNA Biomarkers for Human Glioma$499,999
UH2 · FY2013 · TR
Administration and neuropathology oversight$120,491
P01 · FY2013 · CA · contact PI
ISEV Meeting (International Society of Extracellular Vesicles)$10,000
R13 · FY2013 · CA · contact PI
Experimental Therapeutics and BioMonitoring for Brain Tumors$1,393,267
P01 · FY2012 · CA · contact PI
Administration and neuropathology oversight$133,613
P01 · FY2012 · CA · contact PI
Gene Therapy for Brain Tumors$1,440,815
P01 · FY2010 · CA · contact PI
Administration and Biostatistics$112,801
P01 · FY2010 · CA · contact PI
Gene Therapy for Brain Tumors$1,412,570
P01 · FY2009 · CA · contact PI
Administration and Biostatistics$113,905
P01 · FY2009 · CA · contact PI
Gene Therapy for Brain Tumors$42,486
P01 · FY2009 · CA · contact PI
Gene Therapy for Brain Tumors$1,371,426
P01 · FY2008 · CA · contact PI
Administration and Biostatistics$110,604
P01 · FY2008 · CA · contact PI
Gene Therapy for Brain Tumors$41,424
P01 · FY2008 · CA · contact PI
Gene Therapy for Brain Tumors$1,357,853
P01 · FY2007 · CA · contact PI
Administration and Biostatistics$109,456
P01 · FY2007 · CA · contact PI
Gene Therapy for Brain Tumors$40,392
P01 · FY2007 · CA · contact PI
Gene Therapy for Brain Tumors$1,400,000
P01 · FY2006 · CA · contact PI
Administration and Biostatistics$78,202
P01 · FY2006 · CA · contact PI
GENE THERAPY FOR BRAIN TUMORS$2,241,721
P01 · FY2004 · CA
GENE THERAPY FOR BRAIN TUMORS$2,177,781
P01 · FY2003 · CA
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM$134,083
U01 · FY2003 · CA
GENE THERAPY FOR BRAIN TUMORS$24,966
P51 · FY2003 · RR
GENE THERAPY FOR BRAIN TUMORS$2,095,552
P01 · FY2002 · CA
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM$120,713
U01 · FY2002 · CA
CORE--PRIMATE AND HUMAN CLINICAL TRIALS$0
P01 · FY2002 · CA
GENE THERAPY FOR BRAIN TUMORS$2,035,660
P01 · FY2001 · CA
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM$117,440
U01 · FY2001 · CA
CORE--PRIMATE AND HUMAN CLINICAL TRIALS$0
P01 · FY2001 · CA
GENE THERAPY FOR BRAIN TUMORS$2,022,442
P01 · FY2000 · CA
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM$90,245
U01 · FY2000 · CA
CORE--PRIMATE AND HUMAN CLINICAL TRIALS$0
P01 · FY2000 · CA